Latest News

Some of the news articles below may show only part of the news story. To view the full story, click on Read More below the story. 

  • December 01, 2016 10:42 AM | Deleted user

    Research shows that the proportion of broad-spectrum antibiotic prescriptions varies significantly among physicians, nurse practitioners, physician assistants, and dentists

    Although antibiotic prescriptions are decreasing overall in the U.S., prescriptions of broad-spectrum antibiotics such as penicillin, macrolides, and quinolones are increasing. Because use of broad-spectrum antibiotics can lead to resistance, researchers at the University of Illinois at Chicago, the Centers for Disease Control and Prevention, and IMS Health investigated prescriber trends over time by provider group as a way to customize stewardship efforts.

    In the study, published online in the Journal of the American Pharmacists Association, data from a nationally representative database of outpatient antibiotic prescriptions in the U.S. from January 1, 2005, through December 31, 2010, including oral and injectable systemic antibiotic prescriptions dispensed from retail community pharmacies, mail service pharmacies, and medical clinics, were analyzed. Providers were classified as physicians, nurse practitioners (NPs), physician assistants (PAs), and dentists.

    Results of the study showed that over 6 years, prescriptions for broad-spectrum agents and for antibiotics overall decreased for physicians while increasing for NPs and PAs. They also found that dentists prescribe a large number of antibiotics compared with NPs and PAs. The study authors conclude that interventions should be designed to reverse increasing prescribing trends, especially of broad-spectrum agents prescribed by NPs and PAs, and that stewardship efforts should also be targeted towards dentists.

    Mary Warner, MS, CAE, Senior Director, Periodicals


  • December 01, 2016 10:38 AM | Deleted user

    AAPA
    AAPA Research is now accepting proposals for the ePoster Session at AAPA 2017 in Las Vegas. Both PAs and PA student researchers can submit through Dec. 31. The ePoster Session features original research on case studies, educational innovations and more. Posters will be displayed on site at AAPA 2017 from Monday, May 15, to Friday, May 19.

    Learn more

  • December 01, 2016 10:35 AM | Deleted user

    AAPA
    AAPA is looking for a volunteer to be a medical liaison to the Gay and Lesbian Medical Association (GLMA). Deadline is Dec. 23, so apply today! This individual will represent the PA profession and AAPA to GLMA leaders, communicate between the two organizations, identify strategic opportunities, involve other PAs and raise the PA profile within GLMA.

    Read more

  • November 29, 2016 12:17 PM | Deleted user

    A probable case of local transmission of the Zika virus has been reported in Texas, state health officials announced on Monday, making it the second state, after Florida, in which the infection is thought to have been carried from person to person by mosquitoes.

    The patient is a woman who is not pregnant and lives in Brownsville, on the Gulf Coast near the Mexican border. The state’s first case of chikungunya, a virus spread by the type of mosquito that carries Zika, was confirmed this year in Brownsville.

    Medical investigators must now determine whether the infection is spreading and, if so, how many people may have become infected. Officials have begun asking the woman’s neighbors for urine samples and trapping mosquitoes to test for the virus.

    State and county health officials are working with the Centers for Disease Control and Prevention on the case. The state medical operations center has been activated to help with contact tracing, mosquito surveillance and public education.

    The C.D.C. sent a training team to Texas this year but has not yet been asked to send an emergency response team, said Dr. Thomas R. Frieden, the agency’s director.

    No travel alert suggesting that pregnant women avoid the area will be issued now, Dr. Frieden said, because a single case does not constitute evidence of continuing local transmission. “Most local cases are isolated dead ends,” he said.

    Confirmation of several cases within a roughly one-square-mile area for more than about two weeks, despite aggressive mosquito control, would prompt an alert from federal authorities.

    In Florida this year, the C.D.C. first advised pregnant women to avoid Wynwood, the neighborhood where the first cases in Miami were discovered, and later suggested they avoid all of Miami-Dade County.

    There have now been 4,444 confirmed cases of Zika infection in the continental United States, including 1,114 in pregnant women. Most of those infected had traveled to countries where the virus had been spreading, but 182 of the infections were contracted in Florida by people who had not visited such places.

    The Texas patient, who was not identified, told investigators that she had not traveled recently to anywhere the virus had been spreading. She had no other risk factors, such as having sex with someone who had visited an area with Zika transmission.

    “We knew it was only a matter of time before we saw a Zika case spread by a mosquito in Texas,” said Dr. John Hellerstedt, the state health commissioner.

    Residents of Brownsville, a city of 183,000, are concerned but not fearful, Mayor Tony Martinez said on Monday.

    “I don’t think it’s something that people need to be alarmed about, but by the same token, they need to be cautious about it and report anything that needs to be reported to our health department,” Mr. Martinez said.

    “On the coast, we kind of hoped that it wouldn’t happen,” he added, “but the likelihood was pretty high.”

    Dr. Carmen Rocco, a Brownsville pediatrician, said she had been checking her patients for Zika, but none so far had been infected. Most of her patients are poor enough to be on Medicaid, and she praised state health officials for reinstating a Medicaid benefit for mosquito repellent.

    Journalism that matters.
    More essential than ever.

    SUBSCRIBE TO THE TIMES

    “Families were taking advantage of that,” she said.

    While cold weather is arriving in other parts of the country, southern Texas has had an unusually hot autumn, making it more hospitable to the Aedes aegypti mosquitoes that transmit Zika.

    Even in normal years, Aedes aegypti can persist in the Brownsville area well into December, so new cases may be confirmed in January or later.

    “I predicted last April that we would see cases along the Texas Gulf Coast this summer,” said Dr. Peter J. Hotez, the dean of the National School of Tropical Medicine at Baylor College of Medicine. “This is now the one case we know about, but we don’t know if there are dozens or hundreds.”

    “Because of the lack of funds from Congress, there has been no active surveillance along the Gulf Coast,” he added. “Those cases in Florida were found by serendipity.”

    Chris Van Deusen, a spokesman for the Department of State Health Services in Texas, said the new case was discovered because the woman fell ill and was tested for Zika infection by a local doctor, who alerted public health authorities. All such cases are investigated to see if a patient has a travel history or other risk factors that might explain the infection.

    “Pregnant women should continue to protect themselves from mosquito bites there and elsewhere in Texas,” Mr. Van Deusen said.

    Mosquito control measures will be stepped up, he said, but he did not know if they would involve aerial spraying of pesticides like Naled and larvicides like Bti.

    In the Wynwood section of Miami, mosquito swarms did not decrease enough to stop disease transmission until both types of aerial spraying were used.

    Thousands of Mexicans and Americans cross bridges over the Rio Grande each day in the Brownsville area; it is possible that the virus has been spreading in Matamoros, Mexico, just across the border.

    In 2002, when there was a small outbreak of dengue in Brownsville, Dr. Hotez said, there turned out to be a much larger one in Matamoros. Both cities have poor neighborhoods where residents lack air-conditioning and window screens, he said, but many more Matamoros residents live in poverty.

    “We won’t know how widespread the virus really was until babies with microcephaly begin being born, probably in the spring,” Dr. Hotez said, referring to the Zika virus and its link to the birth defect. “And I expect it to return next year.”

    The C.D.C. regularly collaborates with Mexican health authorities, and Mexico “has quite a strong mosquito control program,” Dr. Frieden said.

    Exactly how much Zika infection there may be in nearby parts of Mexico is unknown. “We know there is transmission in the border areas,” Dr. Frieden said. “But exactly where, we don’t know.”

    A version of this article appears in print on November 29, 2016, on page A11 of the New York edition with the headline: Texas Woman Contracts Zika as Mosquitoes Spread the Virus to a Second State. 


  • November 29, 2016 8:54 AM | Deleted user

    Written by Honor Whiteman

    Published: Monday 28 November 2016

    There is insufficient evidence to suggest breast cancer screening should be stopped at a specific age. This is the conclusion of the largest study to date of mammography outcomes in the United States.

    Researchers say there is no evidence that women should stop having mammograms after a certain age.

    Study co-author Dr. Cindy Lee, assistant professor in residence at the University of California-San Francisco, and team recently presented their findings at the Radiological Society of North America (RSNA) annual meeting, held in Chicago, IL.

    After skin cancerbreast cancer is the most common form of cancer among American women.

    According to the American Cancer Society, around 246,660 new cases of invasive breast cancer will be diagnosed in the U.S. this year, and more than 40,000 women will die from the disease.

    Despite these grim statistics, breast cancer death rates have been falling in the U.S. since the late 1980s - a trend that has been partly attributed to earlier detection as a result of screening.

    Mammography is considered the gold standard of breast cancer screening. The technique involves the use of X-rays to identify early signs of breast cancer, such as calcifications or tumors in breast tissue.

    ADVERTISEMENT

    Register to Receive More Info on Psoriatic Arthritis

    Guidelines issued by the U.S. Preventive Services Task Force (USPSTF) in 2009 recommend that women aged 40-49 at average risk of breast cancer should make an individual, informed decision as to whether they undergo mammography, while women aged 50-74 should undergo mammography every 2 years.

    For women aged 75 and older, however, the USPSTF state that there is insufficient evidence to "assess the balance of benefits and harms of screening mammography."

    Such guidelines are at odds with those from the American Cancer Society, which recommend that women aged 55 and older should undergo mammography every 2 years, and "screening should continue as long as a woman is in good health and is expected to live 10 more years or longer."

    Assessing the mammography outcomes of more than 2.5 million women

    Dr. Lee notes that the conflicting guidelines surrounding the age at which mammography should be stopped have led to much confusion.

    "There has been a lot of controversy, debate and conversation regarding the different breast cancer screening guidelines, even among major national organizations, over the past few years," she adds.

    Dr. Lee points out that previous randomized, controlled trials assessing mammography outcomes have excluded women aged 75 and older, meaning the available data have been based on results of small, observational studies.

    With this in mind, Dr. Lee and team analyzed data from the National Mammography Database. The researchers assessed more than 5.6 million screening programs that took place at 150 facilities across 31 U.S. states between January 2008 and December 2014.

    All in all, the team gathered data from more than 2.5 million women aged 40 and older. The women were divided into age groups by 5-year intervals up to the age of 90 - aged 40-44, 45-49, 50-54, 55-59, and so on.

    'No evidence for age-based mammography cessation'

    In order to determine mammography outcomes for the women in each age group, the researchers applied four standard performance measures: cancer detection rate, recall rate - the percentage of mammograms that require follow-up testing - and positive predictive value for biopsy recommended (PPV2) and biopsy performed (PPV3).

    Positive predictive value represents the number of cancers identified through mammography that result in biopsy or recommended biopsy.

    According to the researchers, a higher cancer detection rate, higher PPV2 and PPV3, and a low recall rate reflect an optimal mammography performance.

    For every 1,000 patients, the team identified an overall mean cancer detection rate of 3.74, a 10 percent recall rate, a 20 percent PPV2 rate, and a 29 percent PPV3 rate.

    With increasing age, the researchers identified an increase in cancer detection rate, a gradual rise in PPV2 and PPV3 rates, and a fall in recall rates - meeting the criteria for ideal screening performance.

    "The continuing increase of cancer detection rate and positive predictive values in women between the ages of 75 and 90 does not provide evidence for age-based mammography cessation."

    Dr. Cindy Lee

    The researchers conclude that their findings suggest it should be a woman's individual choice - based on health status and personal preferences - as to whether she wants to cease or continue breast cancer screening at the age of 75 or older.

    While further investigation is needed, the new research indicates that the benefits of breast cancer screening after the age of 74 may outweigh the risks.

    Read how digital mammography could help predict heart disease.

    Written by Honor Whiteman


  • November 29, 2016 8:52 AM | Deleted user

    Statement by Josanne Pagel following NCCPA’s November 18th PANRE Proposal Communication

    On November 18, 2016, NCCPA announced that it had finalized its plans for modifying PA maintenance of certification requirements. It has discarded its proposal to require PAs to take a closed-book, proctored exam in a specialty area, as well as its plans to introduce either several take-home exams or other new requirements during each 10-year recertification cycle.  NCCPA also announced its intention to modify the PANRE exam to focus on “core knowledge.”

    We are grateful to the many PAs who have made and continue to make their voices heard on this issue.  On their behalf, AAPA welcomes NCCPA’s decision to abandon some of the most onerous parts of its recertification proposal. But we continue to oppose high-stakes recertification exams.

    AAPA opposes re-testing because there is no evidence that it improves patient outcomes or safety. We urge NCCPA to conduct research on the impact of PA recertification exams on patients.

    In the meantime, we will redouble our efforts to remove state laws and regulations that require current NCCPA certification for license renewal.  If we can change these provisions, at least PAs will not be at risk of losing their license if they fail NCCPA’s high stakes recertification exam.  We have already contacted the State Chapters in the 20 states where this requirement exists, and we encourage you to join your State Chapter and help us work on this issue.

    We continue to examine the feasibility of starting a new recertifying organization, and we look forward to a robust conversation on this topic with PAs at AAPA’s Leadership and Advocacy Summit (March 4-5) in Washington, D.C.

    NCCPA Revises Potential Changes to the PA Recertification Exam

    September 19, 2016

    NCCPA advised AAPA, PAEA and ARC-PA at our meeting in Atlanta on September 6 that it is considering an alternative to its previous proposal for recertification testing. NCCPA did not ask the organizations present to endorse its proposal, nor did we offer to do so. We – AAPA, PAEA and ARC-PA – agreed to give NCCPA time to make an official announcement to the PA community before reaching out to our respective stakeholders. NCCPA distributed the alternative they are currently considering by email to PAs on September 9. Over the coming weeks, AAPA’s board will evaluate the new NCCPA proposal in light of AAPA policy, the views of our constituent organizations (COs) and those of individual PAs.

    Listening to and being responsive to our membership is at the heart of AAPA. We will continue to provide transparency in our decision-making and actively seek the opinions of PAs and COs. Please continue making your voices heard by posting your views of the NCCPA alternative on our Facebook page, Twitter #PARecert or in Huddle. You can also send us your views by emailing AAPA at this address: recertificationcomments@aapa.org. We also encourage you to share your views directly with NCCPA.

    arrow
    arrow

    Click here for a printable version of the infographic


  • November 28, 2016 8:16 AM | Deleted user
  • November 28, 2016 8:07 AM | Deleted user

    Black Friday and Cyber Monday are here! While you’re surfing around Amazon to find the perfect gifts, please shop under ARHP’s Amazon Smile portal. ARHP’s receives automatic donations from every Amazon purchase that comes through our account—at no cost to you.

    Easy and fast sign-up is here: à http://www.arhp.org/about-us/support-arhp.

    Please send to your family and friends as well. We actually DO receive a small but helpful check each year from Amazon through the SMILE program. Let’s make this year’s bigger than ever. 


  • November 22, 2016 8:51 AM | Deleted user

    Sexual Health and Your Patients: A Provider’s Guide can help healthcare providers better integrate sexual health conversations and recommended preventive services into routine visits with adolescents and adults. By using this guide, providers can:

    • Streamline their sexual history taking
    • Increase their delivery of recommended preventive sexual health services by using “at a glance” tables

    • Improve their care for LGBT patients 

    • Be better prepared to discuss sexual health topics and answer patient questions 

    • Become more knowledgeable about sexual health

    Explore the guide's sections by clicking on the links below, or download the entire guide by clicking in the box.

    How to Discuss Sexual Health
    Sex can be difficult to discuss, but many patients want to talk about it with you. Get tips for ensuring a productive sexual health conversation with your patients.

    Asking Essential Sexual Health Questions
    Find the essential sexual health questions to ask adults and adolescents at least annually, plus additional questions you can ask to get more information.

    Delivering Recommended Preventive Sexual Health Services
    Preventive services are a key element to improving and protecting sexual health. Find out which your patients should be getting, and which they shouldn't be.

    Responding to Your Patients' Questions
    Not always ready to answer questions about sexual health? See sample responses to common questions so you can include all the important elements in your answers.

    Information About Recommended Screening Tests
    See here for general information about recommended screening tests, including their sensitivity and specificity. 

    Where to Learn More
    Want to learn more about a particular sexual health topic? Visit this list of clinical education and resources.


  • November 21, 2016 2:07 PM | Deleted user

    A new clinical research study seeks to determine whether a rapid molecular diagnostic test can reliably identify gonorrhea infections that may be successfully treated with a single dose of an older antibiotic, ciprofloxacin. The study will enroll up to 381 men and women diagnosed with untreated Neisseria gonorrhoeae. It is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The study is being conducted by the NIAID-funded Sexually Transmitted Infections Clinical Trials Group at four sites: one each in San Francisco, and Philadelphia, and two in Los Angeles.

    The Centers for Disease Control and Prevention estimates that more than 800,000 new gonococcal infections occur in the United States each year. Fewer than half of these infections are detected, and antibiotic-resistant infections are a growing problem. People treated for gonorrhea must now receive two drugs--one orally (azithromycin) and another as an injection (ceftriaxone)--to hedge against the possibility that they may harbor a strain resistant to one of the two drugs. The availability of a greater variety of treatments for gonorrhea--and a tool to pinpoint the best treatment option for each individual--would benefit patients and also potentially help slow the development of drug resistance, say the study authors.

    In this new trial, scientists will employ a rapid molecular assay using swabbed samples from participants' infection sites to determine whether they are infected with gonorrhea of a specific genetic profile (genotype), gyrA serine 91. Participants with that strain who agree to take part in the study will receive one dose of oral ciprofloxacin (500 mg), and will return for clinical and laboratory assessments within 5 to 9 days to determine if they are cured. Participants who remain infected will be referred for standard treatment.

    If the gyrA serine 91 genotype proves to be a reliable marker of vulnerability to ciprofloxacin, healthcare providers may be able to reintroduce ciprofloxacin as a viable treatment for gonorrhea in some cases.

    Source:

    NIH/National Institute of Allergy and Infectious Diseases


Powered by Wild Apricot Membership Software